Quantitative Investment Management, LLC Corcept Therapeutics Inc Transaction History

Quantitative Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $488,482 - $794,730	-29,111 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $180,707 - $289,769	14,503 Added 99.28%	29,111 $506,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $160,688 - $266,742	14,608 New	14,608 $245,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $528,480 - $733,912	-52,273 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $946,661 - $1.33 Million	-78,496 Reduced 60.03%	52,273 $632,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $1.36 Million - $1.92 Million	130,769 New	130,769 $1.85 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $466,505 - $608,652	-47,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $478,430 - $749,367	47,700 New	47,700 $559,000
Q4 2018 Feb 12, 2019	SELL	$11.29 - $17.19 $282,250 - $429,750	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $306,750 - $391,250	25,000 New	25,000 $350,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.